These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3162110)

  • 1. [Treatment of hemorrhoidal crisis with mesoglycan sulfate].
    Saggioro A; Chiozzini G; Pallini P; Di Gilio A; Betetto G; Scassola M; Pezzangora V
    Minerva Dietol Gastroenterol; 1985; 31(2):311-5. PubMed ID: 3162110
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mesoglycan sulfate in acute hemorrhoidal pathology].
    Saggioro A; Chiozzini G
    Minerva Med; 1986 Oct; 77(41):1909. PubMed ID: 2946984
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evidence and rationale of mesoglycan to treat chronic venous disease and hemorrhoidal disease: a narrative review.
    Gallo G; Picciariello A; Tufano A; Camporese G
    Updates Surg; 2024 Apr; 76(2):423-434. PubMed ID: 38356039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic trial of Percase and Percase-L suppositories in hemorrhoidal pathology].
    Héraud M; Paris JC
    Lille Med; 1967 Oct; 12(8):Suppl:842-6. PubMed ID: 4247109
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mesoglycan and fibrinolysis: therapeutic activity of oral mesoglycan in venous thrombosis. A short-term clinical, biological and instrumental study].
    Vittoria A; Cappelli R; Messa GL; Auteri A
    Minerva Med; 1986 Oct; 77(40):1867-72. PubMed ID: 2946002
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic action of oral mesoglycan in the pharmacologic treatment of the varicose syndrome and its complications].
    Petruzzellis V; Velon A
    Minerva Med; 1985 Mar; 76(12):543-8. PubMed ID: 3157887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hemorrhoidal disease: new generation of oral and topical treatments.
    Ratto C; Orefice R; Tiso D; Martinisi GB; Pietroletti R
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9645-9649. PubMed ID: 33015808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of mesoglycan in the prevention of cerebral ischemia].
    Bettini R; Maino C; Gorini M
    Clin Ter; 2003; 154(1):13-6. PubMed ID: 12854278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of mesoglycan therapy in patients with ischemia of the lower limbs. Preliminary results of a new therapeutic protocol].
    Raso AM; Maggio D; Trogolo M; Rispoli P; Sandrone N; Pezzuto D; Bellan A; Melloni CD
    Minerva Cardioangiol; 1997; 45(7-8):383-92. PubMed ID: 9463174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New preparation for the treatment of hemorrhoidal veins].
    Novotný P
    Cas Lek Cesk; 1971; 110(32):774-5. PubMed ID: 5570672
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of acute hemorrhoids].
    Florian A
    Med Monatsschr; 1972 Mar; 26(3):135-6. PubMed ID: 5037494
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of mesoglycan topical treatment of leg ulcers in subjects with chronic venous insufficiency].
    La Marca G; Pumilia G; Martino A
    Minerva Cardioangiol; 1999 Sep; 47(9):315-9. PubMed ID: 10630070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of mesoglycan in patients with cerebrovascular disease: a psychometric evaluation.
    Ambrosio LA; Marchese G; Filippo A; Romano E; Musacchio R
    J Int Med Res; 1993; 21(3):138-46. PubMed ID: 8299857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
    Andreozzi GM
    Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathology and oral therapy of the hemorrhoidal syndrome].
    Aran Suau R; Aran Suau J; Sero Gonzalez J
    Rev Esp Enferm Apar Dig; 1971 Jan; 33(2):253-8. PubMed ID: 4930015
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic activity of oral mesoglycan in venous disease. A clinical and blood coagulation evaluation].
    Bracale GC; Selvetella L; Mirabile F; Ruocco A; Varriale V; De Caterina M
    Minerva Med; 1986 Oct; 77(41):1919-25. PubMed ID: 2946987
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical study of the Ginko biloba--Troxerutin-Heptaminol Hce in the treatment of acute hemorrhoidal attacks.
    Sumboonnanonda K; Lertsithichai P
    J Med Assoc Thai; 2004 Feb; 87(2):137-42. PubMed ID: 15061296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of 2 single oral doses of mesoglycan on the coagulation-fibrinolysis system in man. A pharmacodynamic study].
    Messa G; Blardi P; La Placa G; Puccetti L; Ghezzi A
    Recenti Prog Med; 1995; 86(7-8):272-81. PubMed ID: 7569283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proteolytic enzymes in treating acute thrombophlebitis of hemorrhoidal nodes].
    Geller AN
    Khirurgiia (Mosk); 1972 Feb; 49(2):64-5. PubMed ID: 4572242
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of oral mesoglycan in dermatology].
    Scarsella A; Legge A; Di Stanislao C; Scarsella S
    G Ital Dermatol Venereol; 1988 Jun; 123(6):XXIX-XXXII. PubMed ID: 2975270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.